Olympic Peninsula Kidney Center Coordinated Care Unit in Bremerton, Washington - Dialysis Center

Olympic Peninsula Kidney Center Coordinated Care Unit is a medicare approved dialysis facility center in Bremerton, Washington and it has 4 dialysis stations. It is located in Kitsap county at 2740 Clare Ave, Bremerton, WA, 98310. You can reach out to the office of Olympic Peninsula Kidney Center Coordinated Care Unit at (360) 479-1068. This dialysis clinic is managed and/or owned by Olympic Peninsula Kidney Centers. Olympic Peninsula Kidney Center Coordinated Care Unit has the following ownership type - Non-Profit. It was first certified by medicare in October, 2015. The medicare id for this facility is 502580 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameOlympic Peninsula Kidney Center Coordinated Care Unit
Location2740 Clare Ave, Bremerton, Washington
No. of Dialysis Stations 4
Medicare ID502580
Managed ByOlympic Peninsula Kidney Centers
Ownership TypeNon-Profit
Late Shifts Yes

Contact Information


2740 Clare Ave, Bremerton, Washington, 98310
(360) 479-1068

News Archive

Neutrophils dictate whether our immune system will permit or prevent bacterial infections

New research on a bacterium that can survive encounters with specific immune system cells has strengthened scientists' belief that these plentiful white blood cells, known as neutrophils, dictate whether our immune system will permit or prevent bacterial infections.

Study quantifies cost-benefit of hospital-based program to keep youth out of prison

With violence plaguing inner-city youth at epidemic rates, the report of a new study in the November issue of The Journal of the American College of Surgeons illustrated a research-based approach to confronting this national problem.

Discovery of cause of Job's syndrome

The rare immunodeficiency disorder known as Job's syndrome is caused by a specific genetic mutation that both overstimulates and understimulates the human immune system, leading to harmful bacterial and fungal infections and the physical features characteristic of the syndrome, according to two independent groups of scientists, one from the National Institutes of Health (NIH) and the other from the Tokyo Medical and Dental University.

Inhibitex fourth quarter net loss increases to $7.0 million

Inhibitex, Inc. today announced its financial results for the fourth quarter and year ended December 31, 2010, and provided an update on recent clinical and corporate developments.

Read more Medical News

› Verified 5 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Olympic Peninsula Kidney Center Coordinated Care Unit from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1295142065
Organization NameOpkc Coordinated Care Unit
Doing Business AsOlympic Peninsula Kidney Center
Address2740 Clare Ave Bremerton, Washington, 98310
Phone Number(360) 479-5908

News Archive

Neutrophils dictate whether our immune system will permit or prevent bacterial infections

New research on a bacterium that can survive encounters with specific immune system cells has strengthened scientists' belief that these plentiful white blood cells, known as neutrophils, dictate whether our immune system will permit or prevent bacterial infections.

Study quantifies cost-benefit of hospital-based program to keep youth out of prison

With violence plaguing inner-city youth at epidemic rates, the report of a new study in the November issue of The Journal of the American College of Surgeons illustrated a research-based approach to confronting this national problem.

Discovery of cause of Job's syndrome

The rare immunodeficiency disorder known as Job's syndrome is caused by a specific genetic mutation that both overstimulates and understimulates the human immune system, leading to harmful bacterial and fungal infections and the physical features characteristic of the syndrome, according to two independent groups of scientists, one from the National Institutes of Health (NIH) and the other from the Tokyo Medical and Dental University.

Inhibitex fourth quarter net loss increases to $7.0 million

Inhibitex, Inc. today announced its financial results for the fourth quarter and year ended December 31, 2010, and provided an update on recent clinical and corporate developments.

Read more Medical News

› Verified 5 days ago


Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data30
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL20

News Archive

Neutrophils dictate whether our immune system will permit or prevent bacterial infections

New research on a bacterium that can survive encounters with specific immune system cells has strengthened scientists' belief that these plentiful white blood cells, known as neutrophils, dictate whether our immune system will permit or prevent bacterial infections.

Study quantifies cost-benefit of hospital-based program to keep youth out of prison

With violence plaguing inner-city youth at epidemic rates, the report of a new study in the November issue of The Journal of the American College of Surgeons illustrated a research-based approach to confronting this national problem.

Discovery of cause of Job's syndrome

The rare immunodeficiency disorder known as Job's syndrome is caused by a specific genetic mutation that both overstimulates and understimulates the human immune system, leading to harmful bacterial and fungal infections and the physical features characteristic of the syndrome, according to two independent groups of scientists, one from the National Institutes of Health (NIH) and the other from the Tokyo Medical and Dental University.

Inhibitex fourth quarter net loss increases to $7.0 million

Inhibitex, Inc. today announced its financial results for the fourth quarter and year ended December 31, 2010, and provided an update on recent clinical and corporate developments.

Read more Medical News

› Verified 5 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center15
    Adult patient months included in Kt/V greater than or equal to 1.2137
    Percentage of adult patients getting regular hemodialysis at the center99
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    Neutrophils dictate whether our immune system will permit or prevent bacterial infections

    New research on a bacterium that can survive encounters with specific immune system cells has strengthened scientists' belief that these plentiful white blood cells, known as neutrophils, dictate whether our immune system will permit or prevent bacterial infections.

    Study quantifies cost-benefit of hospital-based program to keep youth out of prison

    With violence plaguing inner-city youth at epidemic rates, the report of a new study in the November issue of The Journal of the American College of Surgeons illustrated a research-based approach to confronting this national problem.

    Discovery of cause of Job's syndrome

    The rare immunodeficiency disorder known as Job's syndrome is caused by a specific genetic mutation that both overstimulates and understimulates the human immune system, leading to harmful bacterial and fungal infections and the physical features characteristic of the syndrome, according to two independent groups of scientists, one from the National Institutes of Health (NIH) and the other from the Tokyo Medical and Dental University.

    Inhibitex fourth quarter net loss increases to $7.0 million

    Inhibitex, Inc. today announced its financial results for the fourth quarter and year ended December 31, 2010, and provided an update on recent clinical and corporate developments.

    Read more Medical News

    › Verified 5 days ago

  • Peritoneal Dialysis
    Adult patients getting regular peritoneal dialysis at the center40
    Adult patient months included in Kt/V greater than or equal to 1.7401
    Percentage of adult patients getting regular peritoneal dialysis at the center85
    Percentage of pediatric patients getting regular peritoneal dialysis at the center

    News Archive

    Neutrophils dictate whether our immune system will permit or prevent bacterial infections

    New research on a bacterium that can survive encounters with specific immune system cells has strengthened scientists' belief that these plentiful white blood cells, known as neutrophils, dictate whether our immune system will permit or prevent bacterial infections.

    Study quantifies cost-benefit of hospital-based program to keep youth out of prison

    With violence plaguing inner-city youth at epidemic rates, the report of a new study in the November issue of The Journal of the American College of Surgeons illustrated a research-based approach to confronting this national problem.

    Discovery of cause of Job's syndrome

    The rare immunodeficiency disorder known as Job's syndrome is caused by a specific genetic mutation that both overstimulates and understimulates the human immune system, leading to harmful bacterial and fungal infections and the physical features characteristic of the syndrome, according to two independent groups of scientists, one from the National Institutes of Health (NIH) and the other from the Tokyo Medical and Dental University.

    Inhibitex fourth quarter net loss increases to $7.0 million

    Inhibitex, Inc. today announced its financial results for the fourth quarter and year ended December 31, 2010, and provided an update on recent clinical and corporate developments.

    Read more Medical News

    › Verified 5 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Olympic Peninsula Kidney Center Coordinated Care Unit with elevated calcium levels.

Patients with hypercalcemia57
Hypercalcemia patient months545
Hypercalcemia patients with serumcalcium greater than 10.2 mg1
Patients with Serumphosphor66
Patients with Serumphosphor less than 3.5 mg/dL5
Patients with Serumphosphor from 3.5 to 4.5 mg/dL18
Patients with Serumphosphor from 4.6 to 5.5 mg/dL30
Patients with Serumphosphor from 5.6 to 7 mg/dL35
Patients with Serumphosphor greater than 7 mg/dL13

News Archive

Neutrophils dictate whether our immune system will permit or prevent bacterial infections

New research on a bacterium that can survive encounters with specific immune system cells has strengthened scientists' belief that these plentiful white blood cells, known as neutrophils, dictate whether our immune system will permit or prevent bacterial infections.

Study quantifies cost-benefit of hospital-based program to keep youth out of prison

With violence plaguing inner-city youth at epidemic rates, the report of a new study in the November issue of The Journal of the American College of Surgeons illustrated a research-based approach to confronting this national problem.

Discovery of cause of Job's syndrome

The rare immunodeficiency disorder known as Job's syndrome is caused by a specific genetic mutation that both overstimulates and understimulates the human immune system, leading to harmful bacterial and fungal infections and the physical features characteristic of the syndrome, according to two independent groups of scientists, one from the National Institutes of Health (NIH) and the other from the Tokyo Medical and Dental University.

Inhibitex fourth quarter net loss increases to $7.0 million

Inhibitex, Inc. today announced its financial results for the fourth quarter and year ended December 31, 2010, and provided an update on recent clinical and corporate developments.

Read more Medical News

› Verified 5 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 16
Patient months included in arterial venous fistula and catheter summaries 119
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment62
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer14

News Archive

Neutrophils dictate whether our immune system will permit or prevent bacterial infections

New research on a bacterium that can survive encounters with specific immune system cells has strengthened scientists' belief that these plentiful white blood cells, known as neutrophils, dictate whether our immune system will permit or prevent bacterial infections.

Study quantifies cost-benefit of hospital-based program to keep youth out of prison

With violence plaguing inner-city youth at epidemic rates, the report of a new study in the November issue of The Journal of the American College of Surgeons illustrated a research-based approach to confronting this national problem.

Discovery of cause of Job's syndrome

The rare immunodeficiency disorder known as Job's syndrome is caused by a specific genetic mutation that both overstimulates and understimulates the human immune system, leading to harmful bacterial and fungal infections and the physical features characteristic of the syndrome, according to two independent groups of scientists, one from the National Institutes of Health (NIH) and the other from the Tokyo Medical and Dental University.

Inhibitex fourth quarter net loss increases to $7.0 million

Inhibitex, Inc. today announced its financial results for the fourth quarter and year ended December 31, 2010, and provided an update on recent clinical and corporate developments.

Read more Medical News

› Verified 5 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary52
Hospitalization Rate in facility196.4 (As Expected)
Hospitalization Rate: Upper Confidence Limit358.5
Hospitalization Rate: Lower Confidence Limit112.2

News Archive

Neutrophils dictate whether our immune system will permit or prevent bacterial infections

New research on a bacterium that can survive encounters with specific immune system cells has strengthened scientists' belief that these plentiful white blood cells, known as neutrophils, dictate whether our immune system will permit or prevent bacterial infections.

Study quantifies cost-benefit of hospital-based program to keep youth out of prison

With violence plaguing inner-city youth at epidemic rates, the report of a new study in the November issue of The Journal of the American College of Surgeons illustrated a research-based approach to confronting this national problem.

Discovery of cause of Job's syndrome

The rare immunodeficiency disorder known as Job's syndrome is caused by a specific genetic mutation that both overstimulates and understimulates the human immune system, leading to harmful bacterial and fungal infections and the physical features characteristic of the syndrome, according to two independent groups of scientists, one from the National Institutes of Health (NIH) and the other from the Tokyo Medical and Dental University.

Inhibitex fourth quarter net loss increases to $7.0 million

Inhibitex, Inc. today announced its financial results for the fourth quarter and year ended December 31, 2010, and provided an update on recent clinical and corporate developments.

Read more Medical News

› Verified 5 days ago

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Olympic Peninsula Kidney Center Coordinated Care Unit were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility27.7 (As Expected)
Readmission Rate: Upper Confidence Limit40.1
Readmission Rate: Lower Confidence Limit17.6

News Archive

Neutrophils dictate whether our immune system will permit or prevent bacterial infections

New research on a bacterium that can survive encounters with specific immune system cells has strengthened scientists' belief that these plentiful white blood cells, known as neutrophils, dictate whether our immune system will permit or prevent bacterial infections.

Study quantifies cost-benefit of hospital-based program to keep youth out of prison

With violence plaguing inner-city youth at epidemic rates, the report of a new study in the November issue of The Journal of the American College of Surgeons illustrated a research-based approach to confronting this national problem.

Discovery of cause of Job's syndrome

The rare immunodeficiency disorder known as Job's syndrome is caused by a specific genetic mutation that both overstimulates and understimulates the human immune system, leading to harmful bacterial and fungal infections and the physical features characteristic of the syndrome, according to two independent groups of scientists, one from the National Institutes of Health (NIH) and the other from the Tokyo Medical and Dental University.

Inhibitex fourth quarter net loss increases to $7.0 million

Inhibitex, Inc. today announced its financial results for the fourth quarter and year ended December 31, 2010, and provided an update on recent clinical and corporate developments.

Read more Medical News

› Verified 5 days ago